Farmaceutica, Longo (AstraZeneca): “Life science strategy crea attrattività per l’Italia”

adnkronos

(Adnkronos) - “Il settore farmaceutico porta avanti valore economico, impatto sociale e attivazione del capitale umano. Lavorare su una ‘Life science strategy’ si può creare attrattività Italia”. Ad affermarlo a Bari nel corso della presentazione di uno studio di The European House Ambrosetti è stato Claudio Longo, Presidente e Amministratore delegato di AstraZeneca in Italia.

Transcript

00:00The project VALORE was a way to show how important the pharmaceutical sector can be.

00:10The pharmaceutical sector from the point of view of Italy's competitiveness,

00:15bringing forward economic value, social impact, but also the activation of human capital.

00:24It is important because we think that working on a life science strategy

00:28we can create an attractiveness of Italy in the European and global competitiveness

00:34to attract more and more what is the innovation of the future,

00:38creating economic value impact, but also resilience of our country and our system.

00:44In this report we have shown that we invest a lot in research,

00:50more than 190 active studies in Italy,

00:54on the whole territory, working in more than 17 regions

00:58and more than 600 clinical structures on the territory of great excellence.

01:04The impact that has been shown is a direct and induced impact

01:08of more than 500 million euros of added value in 2023.

01:12Very important, a multiplier of almost 3,

01:16which means that every euro we have invested has generated almost 3,

01:202.7 euros of impact on the country's system.

Category

Transcript

Recommended